Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.29 billion. The enterprise value is $814.32 million.

Market Cap	1.29B
Enterprise Value	814.32M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ELVN has 59.35 million shares outstanding. The number of shares has increased by 19.30% in one year.

Current Share Class	59.35M
Shares Outstanding	59.35M
Shares Change (YoY)	+19.30%
Shares Change (QoQ)	+19.17%
Owned by Insiders (%)	4.14%
Owned by Institutions (%)	68.61%
Float	37.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.71
P/TBV Ratio	2.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 32.95, with a Debt / Equity ratio of 0.00.

Current Ratio	32.95
Quick Ratio	32.60
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.43% and return on invested capital (ROIC) is -18.34%.

Return on Equity (ROE)	-25.43%
Return on Assets (ROA)	-17.62%
Return on Invested Capital (ROIC)	-18.34%
Return on Capital Employed (ROCE)	-23.57%
Revenue Per Employee	n/a
Profits Per Employee	-$1.57M
Employee Count	62
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.86% in the last 52 weeks. The beta is 1.04, so ELVN's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-10.86%
50-Day Moving Average	20.27
200-Day Moving Average	20.06
Relative Strength Index (RSI)	56.54
Average Volume (20 Days)	614,313

Short Selling Information

The latest short interest is 7.78 million, so 13.11% of the outstanding shares have been sold short.

Short Interest	7.78M
Short Previous Month	6.42M
Short % of Shares Out	13.11%
Short % of Float	20.86%
Short Ratio (days to cover)	18.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-112.27M
Pretax Income	-97.21M
Net Income	-97.21M
EBITDA	-111.97M
EBIT	-112.27M
Earnings Per Share (EPS)	-$1.81

Balance Sheet

The company has $477.57 million in cash and $490,000 in debt, giving a net cash position of $477.08 million or $8.04 per share.

Cash & Cash Equivalents	477.57M
Total Debt	490,000
Net Cash	477.08M
Net Cash Per Share	$8.04
Equity (Book Value)	476.12M
Book Value Per Share	8.03
Working Capital	468.03M

Cash Flow

In the last 12 months, operating cash flow was -$71.67 million and capital expenditures -$158,000, giving a free cash flow of -$71.82 million.

Operating Cash Flow	-71.67M
Capital Expenditures	-158,000
Free Cash Flow	-71.82M
FCF Per Share	-$1.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.30%
Shareholder Yield	-19.30%
Earnings Yield	-7.53%
FCF Yield	-5.56%

Analyst Forecast

The average price target for ELVN is $41.20, which is 89.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.20
Price Target Difference	89.34%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2